Protein-protein interactions (PPIs) are essential for many cellular processes. However, transient PPIs are difficult to measure at high throughput or in complex biological fluids using existing methods. We engineered a genetically encoded sensor for real-time sampling of transient PPIs at singlemolecule resolution. Our sensor comprises a truncated outer membrane protein pore, a flexible tether, a protein receptor and a peptide adaptor. When a protein ligand present in solution binds to the receptor, reversible capture and release events of the receptor can be measured as current transitions between two open substates of the pore. Notably, the binding and release of the receptor by a protein ligand can be unambiguously discriminated in a complex sample containing fetal bovine serum. Our selective nanopore sensor could be applied for single-molecule protein detection, could form the basis for a nanoproteomics platform or might be adapted to build tools for protein profiling and biomarker discovery.
l e t t e r s
Protein-protein interactions (PPIs) are essential for many cellular processes. However, transient PPIs are difficult to measure at high throughput or in complex biological fluids using existing methods. We engineered a genetically encoded sensor for real-time sampling of transient PPIs at singlemolecule resolution. Our sensor comprises a truncated outer membrane protein pore, a flexible tether, a protein receptor and a peptide adaptor. When a protein ligand present in solution binds to the receptor, reversible capture and release events of the receptor can be measured as current transitions between two open substates of the pore. Notably, the binding and release of the receptor by a protein ligand can be unambiguously discriminated in a complex sample containing fetal bovine serum. Our selective nanopore sensor could be applied for single-molecule protein detection, could form the basis for a nanoproteomics platform or might be adapted to build tools for protein profiling and biomarker discovery.
Physical associations between proteins (protein-protein interactions, PPIs) underpin cell functions in normal and pathogenic conditions and are important therapeutic targets 1 . Existing methods detect transient PPIs at high spatial resolution using single-molecule technologies [2] [3] [4] , but these methods are limited by low throughput. Conventional methods such as biolayer interferometry 5 and surface plasmon resonance 6 have been used in the affinity, kinetic and thermodynamic determinations of transient PPIs in bulk phase. Both are real-time techniques that can be used at high throughput. Surface plasmon resonance is limited by nonspecific protein binding on surfaces, surface heterogeneity, protein inactivation at the liquid-metal film interface, and molecular crowding effects. Isothermal titration calorimetry 7 can report binding kinetics but is not high throughput and requires large quantities of proteins. Biolayer interferometry, surface plasmon resonance, and isothermal titration calorimetry provide average kinetic or affinity parameters and cannot be used in a heterogeneous sample.
Transient PPIs can be measured using a resistive-pulse technique 8 and solid-state nanopores that are large enough to permit tethering of protein receptors on their internal surface 9, 10 . However, accurate identification of the anchoring site for tethered protein receptors remains difficult, which limits the sensitivity of single-molecule measurements. An alternative approach to these shortcomings is the detection of reversible PPIs using an engineered protein nanopore. Protein nanopores have the advantage of being modifiable with atomic precision. Furthermore, sensing with engineered biological nanopores is amenable to integration into nanofluidic devices and high-throughput technologies 11 . Biological nanopores could theoretically couple molecular precision with a parallel format [12] [13] [14] [15] [16] .
Two requirements must be fulfilled to measure binding events between two folded proteins in solution using a protein nanopore. First, reversible PPIs must occur in the aqueous phase, because the dimensions of a protein-protein complex exceed the cross-sectional internal diameter of protein nanopores. Therefore, these interactions can only be detected outside the nanopore lumen [17] [18] [19] . Second, a transducing mechanism is required to convert the reversible physical association and dissociation of the two interacting protein partners in the aqueous phase into a high-fidelity electrical signature of the nanopore sensor.
We report an engineered protein nanopore sensor that can detect reversible PPIs in solution and at single-tethered-receptor resolution. Because the detection of binding events occurs outside the lumen of the nanopore, we can apply our sensor to probe transient PPIs in mammalian serum. A single-polypeptide protein was created using t-FhuA 20 , a monomeric β-barrel scaffold that is a truncated version of ferric hydroxamate uptake component A (FhuA) 21 from Escherichia coli (Fig. 1a, top) . A protein receptor (the 110amino acid RNase barnase (Bn) 22 ) was fused to t-FhuA, on the β-turns side, with a flexible (GGS) 2 hexapeptide tether (Online Methods and Supplementary Tables 1 and 2 ). An H102A mutant of Bn was used because this lacks RNase activity 22, 23 , which in turn ensures that Bn-FhuA fusion proteins are not toxic to the expression host (Online Methods). The 455-residue t-FhuA scaffold formed a transmembrane pore 20 , facilitating a quiet single-channel electrical signature for long periods when added to the cis side of the chamber ( Supplementary  Fig. 1 ). Both t-FhuA termini are accessible to the β-turns opening of the pore (Fig. 1a , top). We tested two protein pore nanostructures, in which Bn was fused to either the N terminus (Bn(GGS) 2 t-FhuA) or the C terminus (t-FhuA(GGS) 2 Bn) of t-FhuA. The average singlechannel conductance noted with t-FhuA was 1.6 ± 0.1 nS (n = 6) at a transmembrane potential of −40 mV and in 300 mM KCl, 10 mM Tris-HCl, pH 8 ( Supplementary Fig. 1 ). Bn(GGS) 2 t-FhuA and l e t t e r s t-FhuA(GGS) 2 Bn showed average single-channel conductance values that were similar to that recorded with t-FhuA. Bn(GGS) 2 t-FhuA and t-FhuA(GGS) 2 Bn also exhibited stability of the open-state current for long periods. These results suggest that Bn is located outside the pore lumen, on the β-turns side of t-FhuA. Moreover, these findings indicate that t-FhuA tolerates large polypeptide extensions at either terminus without affecting its pore-forming ability.
The protein ligand we used in our initial set of measurements was the 89-residue barstar (Bs) 24 , which is an inhibitor of Bn RNase activity. Surprisingly, the addition of 201.6 nM Bs to the cis side, Figure 1 Measuring high-affinity PPIs using a nanopore sensor. (a) Top, a protein pore-based nanostructure for the real-time sampling of transient PPIs.
The single-polypeptide protein comprises a t-FhuA protein pore scaffold, a flexible (GGS) 2 tether, a barnase (Bn) protein receptor and an O peptide adaptor. The schematic model was created in PyMol using the Protein Data Bank files 1BY3 (FhuA) 21 and 1BRS (Bn-Bs) 34 l e t t e r s either with reconstituted Bn(GGS) 2 t-FhuA or with t-FhuA(GGS) 2 Bn, failed to produce reversible alterations in the electrical signature ( Supplementary Fig. 2 ). It is possible that the Bn receptor adopts a conformation that blocks the accessibility of its binding site to Bs, or that Bn-Bs interactions in solution are indistinguishable (electrically silent) in the readout. We favor the hypothesis that Bn does not obstruct ionic flux through the pore, and that transient Bn-Bs complex formation pulls Bn away from the pore opening. This hypothesis relies on single-channel measurements using t-FhuA, whose electrical signature is indistinguishable from those recorded either with Bn(GGS) 2 t-FhuA or t-FhuA(GGS) 2 Bn (Supplementary Fig. 1) .
To obtain an altered single-channel electrical signature of Bn(GGS) 2 t-FhuA that might be sensitive to Bn-Bs specific interactions, we fused a 12-residue peptide adaptor (O) to the N terminus of Bn, resulting in OBn(GGS) 2 t-FhuA ( Fig. 1a , top, and Supplementary  Fig. 3a ). Our peptide adaptor has an unstructured and slightly negatively charged sequence 25 that should span the distance between the N terminus of Bn (its fusion point) and the pore opening. This distance is ~4 nm, assuming that the flexible (GGS) 2 linker is extended. We hypothesized that this peptide adaptor would exhibit nonspecific interactions with the highly acidic entrance of the pore, resulting in a distinct and sensitive electrical signature. We found that OBn(GGS) 2 t-FhuA had a reduced unitary conductance of 1.23 ± 0.03 nS (n = 8) at a transmembrane potential of −40 mV ( Supplementary Fig. 3b,c) . Further, OBn(GGS) 2 t-FhuA exhibited frequent, brief, and upwards current spikes ( Supplementary Figs. 4 and 5) . The fusion of the peptide adaptor to the N terminus of Bn(GGS) 2 t-FhuA likely induces an l e t t e r s obstruction moiety near the pore opening of t-FhuA, thereby reducing its unitary conductance. Remarkably, when Bs was added to the cis side in the nanomolar range, we detected reversible current transitions between O on , a lower-current-amplitude open substate, and O off , a higher-currentamplitude open substate (Fig. 1a, bottom, Fig. 1b and Supplementary  Table 3 ). We interpret these current transitions as reversible capture (O off ) and release (O on ) events of Bn by Bs. We hypothesize that the transient capture events are accompanied by pulling the obstruction moiety away from the pore opening, increasing the open-state current to O off . This level is closely similar to that noted with Bn(GGS) 2 t-FhuA ( Supplementary Fig. 3b ). This interpretation is in accord with a quieter and higher-conductance open substate of the capture events ( Supplementary Figs. 4 and 6) .
The current amplitudes of O off and O on enabled an unambiguous separation of the 'off ' (quiet substate) and 'on' (noisy substate) events, with a difference of 10 ± 2 pA (n = 3). Notably, reversible current transitions were only observed when Bs was added to the cis side, but not to the trans side ( Supplementary Fig. 7) , which confirmed that the truncated FhuA protein pores insert into the lipid bilayer with a preferred orientation 26, 27 . The pore is inserted such that the loops face the trans side and the β turns face the cis side ( Fig. 1a, top) 20 .
Next we tested the single-molecule kinetics of the Bn-Bs interactions and found that the frequency of Bn-Bs binding events increased with Bs concentration (Fig. 1b) . Semilogarithmic representations of the interevent duration, τ on , and dwell time, τ off , analyses are shown in Figure 1c and Figure 1d , respectively. Note that the center location of the peak is the logarithm of the time constant. The standard interevent duration and dwell-time analyses of the 'on' and 'off ' events are illustrated in Supplementary Figures 8 and 9 , respectively. We applied a logarithm likelihood ratio test to fit models of these histograms ( Fig. 1c,d) , and this showed that 'on' and 'off ' events had a singleexponential-value distribution, suggesting a single-barrier transition of the free-energy landscape of these PPIs.
The frequency of the Bn-Bs binding events in the form of 1/τ on was linearly dependent on the Bs concentration, confirming a bimolecular association process (Fig. 1e) . The slope of the linear fit of event frequency was the association rate constant k on . The reciprocal of the τ off duration, which is the dissociation rate constant k off , was independent of the Bs concentration, confirming a unimolecular dissociation process. We obtained k on = (1.34 ± 0.04) × 10 7 M −1 s −1 and k off = 0.86 ± 0.02 s −1 , corresponding to an equilibrium dissociation constant K d of 64 ± 02 nM (Supplementary Table 4 ). The value of this constant indicated a high-affinity PPI of the Bn-Bs pair. This agrees well with previous kinetic measurements of Bn-Bs interactions 22, 23 . Furthermore, we found that the signal-to-noise ratio was not increased by an increase in Bs concentration, even in the low micromolar range (Supplementary Fig. 10) . At higher Bs concentrations, the frequency of PPI events showed a nonlinear dependence on protein concentration, likely owing to saturation of the Bn binding site (Supplementary Fig. 11) .
Weak PPIs, with K d values in the micromolar or millimolar range, are important in many signaling pathways 28 . The main difficulty in detecting weak PPIs is either high-dissociation or low-association rate constants, or both 2 . To test the ability of OBn(GGS) 2 t-FhuA to detect weaker PPIs, we carried out single-channel recordings using D39A Bs, a Bs variant with greatly reduced binding affinity to Bn. When a low-nanomolar concentration of D39A Bs was added to the cis side, reversible current transitions occurred between O on and O off , but with a binding duration in the low-millisecond range. τ off was much shorter than the value for the Bn-Bs pair (Fig. 2a) . This weak interaction had interevent duration ( Fig. 2b) and dwell-time ( Fig. 2c ) histograms with single-exponential distributions. The standard interevent duration and dwell-time analyses of the corresponding 'on' and 'off ' events are reported in Supplementary Figures 12 and  13 , respectively. τ on decreased when D39A Bs concentration was increased ( Supplementary Table 5 ) whereas there was no statistically significant alteration in τ off when D39A Bs concentration was changed. The frequency of low-affinity events increased linearly with increasing the D39A Bs concentration, consistent with our results using high-affinity binder Bs (Fig. 2d) . Our finding of k on = (0.193 ± 0.003) × 10 7 M −1 s −1 and k off = 281 ± 8 s −1 , to yield a K d of 146 ± 4 µM ( Supplementary Table 4 ), is consistent with earlier studies carried out in bulk phase 23 . For example, in 50 mM Tris-HCl, pH 8, transient PPIs between Bn and D39A Bs had k off and K d values of ~17 s −1 and ~39 nM, respectively. These PPIs are about two orders of magnitude weaker than those recorded for Bn and Bs, which had a K d of ~0.32 nM in the same conditions. This shows that our nanopore sensor can detect transient PPIs at protein ligand concentrations several orders of magnitude below the measured K d . Transient PPIs cannot easily be measured at millisecond-time resolution with other biophysical l e t t e r s methods in solution 28 whereas our nanopore sensor shows promise for detecting weak PPIs with high k off values. An ability to detect multiple analytes in a mixture of proteins is needed for diagnostic applications, and we next tested whether our sensor could identify low-and high-affinity PPIs in a mixture. When both Bs and D39A Bs were added, we detected both long-lived and brief transitions (Fig. 3a,b and Supplementary Tables 6 and 7) . Increasing the concentration of high-affinity Bs resulted in an increase in the frequency of long-lived current transitions and a reduction in the frequency of the brief binding events. These experiments revealed that our nanopore sensor can discriminate competitive interactions between two Bs variants for the same binding site.
We also tested whether our sensor could detect Bs in the presence of fetal bovine serum (FBS). In the absence of Bs, OBn(GGS) 2 t-FhuA exhibited a uniform and quiet unitary current at a transmembrane potential of −15 mV (n = 3; Fig. 4a, upper trace) . Single-channel traces acquired with OBn(GGS) 2 t-FhuA in the presence of 12.6 nM Bs, which was added to the cis side, displayed reversible low-current amplitude transitions between O on and O off (n = 3; Fig. 4a , middle trace). In the presence of 5% (v/v) FBS, large-amplitude current blockades were recorded, more than likely produced by serum constituents that partitioned into the pore lumen (n = 3; I FBS ; Fig. 4a , bottom trace). However, the single-channel electrical traces also showed lowamplitude, PPIs-induced current transitions that were unambiguously distinguished from large-amplitude current blockades (n = 3; Fig. 4b ).
We chose a voltage of −15 mV because at a greater transmembrane potential of −40 mV the FBS-produced current blockades were very long (Supplementary Fig. 14) . These long-lived blockades precluded a precise evaluation of the kinetic rate constants. Notably, the transient PPIs recorded at transmembrane potentials of −15 and −40 mV displayed no statistically significant distinctions in kinetic rate constants (Supplementary Tables 3, 4 and 8) .
Representative standard histograms acquired in the absence and presence of 5% (v/v) FBS are displayed in Figure 4c and Figure 4d , respectively. Notably, k on and k off values of the transient PPI in the absence and presence of FBS were similar (Supplementary Table 8) .
To test the sensitivity of our single-molecule sensor, we determined the Bs concentration in the presence of FBS using C Bs = 1/(τ on k on ), where C Bs , τ on and k on are the concentration of the sampled Bs protein, interevent duration determined in the presence of FBS, and association rate constant inferred for Bs in the absence of FBS, respectively. The average Bs concentration was 13.3 ± 5.0 nM (n = 3). This value is in agreement with the actual Bs concentration added to the cis chamber (12.6 nM Bs). Therefore, our nanopore sensor can detect and quantify a protein analyte in a complex biological fluid. Further, we were able to obtain detailed kinetic information of the transient PPIs even in these challenging conditions.
Most biophysical approaches for the quantification of kinetics of transient PPIs are carried out in bulk phase and report average measurements of an ensemble of proteins in solution. In contrast, l e t t e r s our method has the potential to detect and characterize subpopulations of distinct binding events in a complex biofluid environment. Furthermore, our genetically encoded sensor shows promise for the identification of rare and brief binding events, which to our knowledge cannot be detected using existing technologies. We also anticipate that temperature-dependent electrical recordings might be able to illuminate enthalpic and entropic contributions to kinetic rate constants of association and dissociation of transient PPIs. Simultaneous determination of the k off values for more than one protein target, while providing the apparent k on and half-maximal inhibitory concentration values, is quite a challenging task employing other techniques in solution. Using our single-molecule nanopore sensor, we were able to examine competitive protein interactions with the same binding site. We have shown that our nanopore sensor can probe k off in the range of 10 2 -10 3 s −1 . There is no theoretical reason to suggest that our sensor could not resolve even shorter PPIs events that have even faster dissociation rate constants, such as extremely weak PPIs involved in the rapid responses of cell signaling 2 . Because our sensor is genetically encoded, we envisage that it could form the basis of a combinatorial sensor library of different protein receptors with potential application in clinical nanoproteomics, or high-throughput screening of small-molecule drugs or peptide inhibitors. Finally, the ability to distinguish a specific PPI in a complex biological fluid sample reveals the potential of this sensor for singlemolecule protein detection [29] [30] [31] [32] [33] in cell lysates, biopsies or blood.
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Methods, including statements of data availability and any associated accession codes and references, are available in the online version of the paper.
Note: Any Supplementary Information and Source Data files are available in the online version of the paper.
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ONLINe MetHOds
Design and mutagenesis of the expression constructs. All of the designed genes were constructed using conventional and assembly PCR techniques, and cloned into the expression vector pPR-IBA1 using respective restriction sites. bn(ggs) 2 t-fhua, which encodes barnase (Bn) 34 at the N terminus of the heavily truncated t-FhuA protein 20 via a flexible glycine-and serine-rich tether and BsaI site, was prepared from the bn and t-fhua genes using three PCR reactions. The first PCR reaction was performed using bn as a template DNA, the forward primer (1) ( Supplementary Table 1 ) and reverse primer (2) . The second PCR reaction was performed using t-fhua as a template DNA, with the forward primer (3) and reverse primer (4) . The third PCR reaction was performed using PCR 1 and PCR 2 products as a template DNA, with the forward primer (1) and reverse primer (4) . obn[ggs] 2 t-fhua, which encoded the peptide adaptor, O, MGDRGPEFELGT, fused to the N terminus of Bn; a flexible glycine-and serine-rich tether; t-FhuA; and a KpnI site at the 5′ and 3′ ends, was prepared from the bn and t-fhua genes via three PCR reactions. The first PCR reaction was performed using bn as a template DNA, along with the forward primer (5) and reverse primer (6) . For the second PCR reaction, t-fhua was used as a template DNA, with the forward primer (7) and reverse primer (4) . The third PCR reaction was performed using PCR 1 and PCR 2 products as a template DNA, with the forward primer (5) and reverse primer (4) . The bs gene encoded the barstar (Bs) protein ligand. We removed all the purification tags from the plasmid (plasmid courtesy of Andreas Matouschek) using the forward primer (8) and reverse primer (9) , then subcloned it into the pPR-IBA1 expression vector using BsaI restriction sites. The bs gene also encoded a double alanine mutant, C40A/C82A (ref. 35). The gene encoding D39A Bs was prepared by performing an inverse PCR using the forward primer (10) and reverse primer (11) .
Protein expression and purification. All of the constructed genes were transformed into E. coli BL21(DE3) cells for protein expression. Bn(GGS) 2 t-FhuA, t-FhuA(GGS) 2 Bn and OBn(GGS) 2 t-FhuA were expressed and purified as previously described 20 . In the case of Bs and D39A Bs, transformed cells were grown in Luria-Bertani medium at 37 °C until OD 600 reached a value of ~0.5, after which the temperature was changed to 20 °C. Bs expression was initiated by inducing the cells with IPTG when OD 600 was ~0.7. After induction, the cells were further cultured for another ~18 h at 20 °C. Then the cells were centrifuged at 3,700g for 30 min at 4 °C, followed by their resuspension in 150 mM KCl, 50 mM Tris-HCl, 5 mM EDTA, pH 8. The cell lysis was accomplished using a Model 110L microfluidizer (Microfluidics, Newton, MA). Cell lysates were centrifuged at 108,500g for 30 min at 4 °C to separate the insoluble pellet and supernatant. The supernatant was further processed for ammonium sulfate precipitation. In the first step, ammonium sulfate was slowly dissolved into the supernatant to a final concentration of 10% (w/v) at 4 °C for 30 min. Next the supernatant was centrifuged at 108,500g for 30 min at 4 °C to separate the precipitate and supernatant. The supernatant was then processed as in the previous step with 40% ammonium sulfate. The collected supernatant was dialyzed extensively against 20 mM Tris-HCl, pH 8, overnight at 4 °C. Dialyzed supernatant was then purified on a Q-Sepharose column (Bio-Rad, Hercules, CA) using a linear salt gradient of 0-1 M KCl, 20 mM Tris-HCl, pH 8.
Pure fractions were further passed through the Superdex-75 size-exclusion column (SEC; GE Healthcare Life Sciences, Pittsburg, PA) as a refining purification step. Pure Bs variants were stored at −80 °C. Protein purity was tested by SDS-PAGE analysis.
Protein refolding. Lyophilized Bn(GGS) 2 t-FhuA, t-FhuA(GGS) 2 Single-channel electrical recordings using planar lipid bilayers. Singlemolecule electrophysiology measurements employed planar lipid bilayers, as previously reported 26 . The proteins were added to the cis compartment, which was at ground, to a final concentration ranging between 0.3 and 1 ng/µl. Singlechannel electrical currents were acquired using an Axopatch 200B patch-clamp amplifier (Axon Instruments, Foster City, CA). For all experiments, the electrolyte solution contained 300 mM KCl, 10 mM Tris-HCl, pH 8. Single-channel current transitions were collected from individual electrical traces, whose durations ranged from 10 to 15 min. For both data acquisition and analysis, the pClamp 10.5 software package (Axon) was used. Figures were prepared using ClampFit 10.7 (Axon) and Origin 8.5 (OriginLab, Northampton, MA). A logarithm likelihood ratio test was used for the single-exponential fit of the histograms 36 . All single-channel electrical recordings were acquired at a temperature of 23 ± 1 °C.
Detection of Bs in FBS.
Gibco FBS, catalog no. A3160601, was obtained from Fisher Scientific (Pittsburgh, PA). FBS was sterile-filtered using an 0.2-µm filter and kept at −80 °C for long-term storage. A fresh aliquot of this frozen serum was thawed at 4 °C and incubated at room temperature for at least 30 min before the single-channel experiment.
Reporting Summary. Further information on research design is available in the Nature Research Reporting Summary linked to this article.
Data availability.
The data that support the findings of this study are available from the corresponding author upon reasonable request. 
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Experimental design 1. Sample size
Describe how sample size was determined.
The sample size was determined using standard single-channel analysis and logarithm likelihood ratio (LLR) tests.
Data exclusions
Describe any data exclusions.
No data were excluded from this analysis.
Replication
Describe the measures taken to verify the reproducibility of the experimental findings.
Experiments were performed using samples from different protein preparations. All the experiments were performed independently under similar experimental conditions on different days.
Randomization
Describe how samples/organisms/participants were allocated into experimental groups. This is not relevant to our study, because of the uniform time-constant data, which followed single-exponential distributions.
Blinding
Describe whether the investigators were blinded to group allocation during data collection and/or analysis. This is not relevant for the reason detailed above.
Note: all in vivo studies must report how sample size was determined and whether blinding and randomization were used.
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Clearly defined error bars in all relevant figure captions (with explicit mention of central tendency and variation)
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